Andrew Hwang

Andrew Hwang practices at Riverside Community Hospital in Riverside, California, part of HCA Healthcare.

Andrew Hwang's NPI, 1114458809, was assigned on March 23, 2017. Andrew Hwang graduated from St. George's University School of Medicine in 2017. Andrew Hwang holds California license A162469.

Andrew Hwang's primary practice is Riverside Community Hospital, at 4445 Magnolia Avenue, Riverside, CA 92501 in Riverside County. The practice phone is (951) 788-3000.

Andrew Hwang's primary practice is Riverside Community Hospital in Riverside, California, part of HCA Healthcare. The medical group on file is Alertive Healthcare Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Andrew Hwang practices. Vendor and product names are available with a free account.

Internal medicine is Andrew Hwang's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Andrew Hwang is board certified in hematology by the American Board of Internal Medicine. Andrew Hwang is licensed in California.

Dmand AI lists acute stomach ulcer, anemia, chest pain, circulation problems, circulatory problems in extremities, cirrhosis, congestive heart failure and epilepsy among the conditions Andrew Hwang treats.

CMS data shows 431 Medicare services from Andrew Hwang across 5 procedure codes in 2024, for 132 Medicare patients. Medicare paid $33,363 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 132 Medicare patients who saw Andrew Hwang in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 55% are also on Medicaid. Their average risk score is 3.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Andrew Hwang's median patient age at 64, with 44% women.

In 2024, Andrew Hwang wrote 68 Medicare Part D claims for 25 patients. 90% of them were for generic drugs.

Andrew Hwang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Andrew Hwang, published from 2018 to 2023. 2018 was the busiest year, with 2. The most frequent topics are Antibodies, Monoclonal, Humanized and Antineoplastic Agents, Immunological. Andrew Hwang has published most often in J Oncol Pharm Pract. Andrew Hwang's most frequent co-authors are Constantin Dasanu, MD, PhD, Andrew Samir Iskandar, MD and Haifaa Abdulhaq, MD.

CMS Open Payments shows 10 general payments to Andrew Hwang from 4 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $125.

Andrew Hwang graduated from St. George's University School of Medicine in 2017.

Andrew Hwang is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.